Fennec Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell FENC and other ETFs, options, and stocks.About FENC
Fennec Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric cancer patients.
CEORostislav C. Raykov
CEORostislav C. Raykov
Employees29
Employees29
HeadquartersDurham, North Carolina
HeadquartersDurham, North Carolina
Founded1996
Founded1996
Employees29
Employees29
FENC Key Statistics
Market cap266.94M
Market cap266.94M
Price-Earnings ratio-15.85
Price-Earnings ratio-15.85
Dividend yield—
Dividend yield—
Average volume117.02K
Average volume117.02K
High today$9.84
High today$9.84
Low today$9.46
Low today$9.46
Open price$9.60
Open price$9.60
Volume154.21K
Volume154.21K
52 Week high$11.92
52 Week high$11.92
52 Week low$6.30
52 Week low$6.30
FENC News
Simply Wall St 18h
Risks To Shareholder Returns Are Elevated At These Prices For Fennec Pharmaceuticals Inc. - Simply Wall StWith a median price-to-sales (or "P/S") ratio of close to 12.9x in the Biotechs industry in the United States, you could be forgiven for feeling indifferent abo...
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%